Epstein-Barr virus.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D002051:Burkitt Lymphoma / Q000235:genetics / Q000821:virology; D002277:Carcinoma / Q000235:genetics / Q000821:virology; D002471:Cell Transformation, Neoplastic; D002472:Cell Transformation, Viral; D004195:Disease Models, Animal; D015967:Gene Expression Regulation, Viral; D005814:Genes, Viral / Q000235:genetics; D006566:Herpesviridae Infections / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification; D006689:Hodgkin Disease / Q000235:genetics / Q000821:virology; D006801:Humans; D016867:Immunocompromised Host; D008228:Lymphoma, Non-Hodgkin / Q000235:genetics / Q000821:virology; D009303:Nasopharyngeal Neoplasms / Q000235:genetics / Q000821:virology; D014412:Tumor Virus Infections / Q000175:diagnosis / Q000235:genetics / Q000517:prevention & control; D014764:Viral Proteins / Q000235:genetics; D014765:Viral Vaccines
D000998:Antiviral Agents; D014764:Viral Proteins; D014765:Viral Vaccines